Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793482693 ◽

2013 ◽

Author(s):

Hashim Hashim ◽

Riyad Almousa

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

OnabotulinumtoxinA 100U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Yearbook of Urology ◽

10.1016/j.yuro.2014.03.010 ◽

2014 ◽

Vol 2014 ◽

pp. 65-67

Author(s):

E.S. Rovner

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793477069 ◽

2013 ◽

Author(s):

Howard Goldman

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2013.04.001 ◽

2013 ◽

Vol 64 (2) ◽

pp. 249-256 ◽

Cited By ~ 216

Author(s):

Christopher Chapple ◽

Karl-Dietrich Sievert ◽

Scott MacDiarmid ◽

Vik Khullar ◽

Piotr Radziszewski ◽

...

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2009.02209.x ◽

2009 ◽

Vol 63 (12) ◽

pp. 1702-1714 ◽

Cited By ~ 38

Author(s):

M. D. Vardy ◽

H. D. Mitcheson ◽

T.-A. Samuels ◽

J. D. Wegenke ◽

S. Forero-Schwanhaeuser ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Symptom Bother ◽

Patient Reported ◽

QUALITY OF LIFE IN PATIENTS WITH SYMPTOMS OF OVERACTIVE BLADDER AND REFRACTORY IDIOPATHIC DETRUSOR OVER ACTIVITY FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN TYPE A: RESULTS FROM A RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(06)60681-7 ◽

2006 ◽

Vol 5 (2) ◽

pp. 191 ◽

Cited By ~ 1

Author(s):

A. Sahai ◽

S. Khan ◽

P. Dasgupta

Keyword(s):

Quality Of Life ◽

Botulinum Toxin ◽

Overactive Bladder ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Double Blind Placebo

OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial

European Urology ◽

10.1016/j.eururo.2012.03.005 ◽

2012 ◽

Vol 62 (1) ◽

pp. 148-157 ◽

Cited By ~ 47

Author(s):

Clare J. Fowler ◽

Stephen Auerbach ◽

David Ginsberg ◽

Douglass Hale ◽

Piotr Radziszewski ◽

...

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Health Related Quality ◽

Double Blind ◽

Double Blind Placebo ◽

Related Quality ◽

Health Related ◽

Dose Ranging

The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women

BJU International ◽

10.1046/j.1464-410x.2002.02963.x ◽

2002 ◽

Vol 90 (6) ◽

pp. 544-549 ◽

Cited By ~ 125

Author(s):

C.H. Van Der Vaart ◽

J.R.J. De Leeuw ◽

J.P.W.R. Roovers ◽

A.P.M. Heintz

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Young Women ◽

Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2017.10.018 ◽

2018 ◽

Vol 199 (4) ◽

pp. 998-1003 ◽

Cited By ~ 18

Author(s):

Rui Almeida Pinto ◽

Daniel Costa ◽

Afonso Morgado ◽

Pedro Pereira ◽

Ana Charrua ◽

...

Keyword(s):

Quality Of Life ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Single Center ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo ◽

Re: OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients with Urinary Incontinence due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial

The Journal of Urology ◽

10.1016/j.juro.2013.02.3225 ◽

2013 ◽

Vol 189 (6) ◽

pp. 2205-2206

Author(s):

Alan J. Wein

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Health Related Quality ◽

Double Blind ◽

Double Blind Placebo ◽

Related Quality ◽

Health Related ◽

Dose Ranging